Raymond James & Associates’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,000	Closed	-$41.1K	–	4026
2024 Q1	$41.1K	Hold	10,000	–	–	﹤0.01%	3782
2023 Q4	$42.2K	Buy	+10,000	New	+$42.2K	﹤0.01%	3674
2016 Q2	–	Sell	-19,051	Closed	-$159K	–	2959
2016 Q1	$159K	Buy	+19,051	New	+$159K	﹤0.01%	2619